Searched for
ICHNOS SCIENCES
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsGiven multiple issues that have suddenly come up, there is a high probability that the market will remain volatile. But history tells us th...- Glenmark, AbbVie ink $700 million drug licensing dealGlenmark Pharmaceuticals has entered into a significant agreement with AbbVie to commercialize its investigational drug, ISB 2001, targetin...
- Glenmark’s blood cancer drug ISB 2001 shows promising results in trialIchnos Glenmark Innovation's ISB 2001 has shown promising results in treating relapsed or refractory multiple myeloma (RRMM), demonstrating...
- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...
- Glenmark forms alliance with Ichnos to develop anti-cancer drugsGlenmark Pharmaceuticals and Ichnos Sciences have formed an alliance called Ichnos Glenmark Innovation (IGI) to accelerate cancer drug disc...
- Glenmark bets on respiratory drug, licensing deals to improve businessGlenmark had gross debt of ₹3,765 crore as of June 30, 2022. The company over the years accumulated debt to fund its innovation-led R&D and...
- Stocks in the news: Vodafone Idea, Tata Steel, Sun Pharma, Adani Transmission & ZEELIndia Ratings and Research (Ind-Ra) said it has upgraded Tata Steel's long-term issuer rating to 'AA+' from 'AA'.
- Glenmark looks to license out second drug assetGlenmark chairman and managing director Glenn Saldanha said one of the corporate objectives of the Mumbai-headquartered company is to do at...
- Stocks in the news: ITC, Vedanta, SBI, Emami, HDFC and NatcoMulti-business conglomerate ITC has not given any concrete plan for demerger and listing of businesses to unlock value at its analyst meet.
- Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...
- Add Glenmark Pharmaceuticals, target price Rs 607: ICICI SecuritiesGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 14885.78 Crore) operating in ...
- Glenmark soars over 21% on CLSA’s upgradeThe stock has fallen over 42 per cent in the last one year.
Load More
